EA199800180A1 - Карбапенемовый антибиотик, композиция и способ получения - Google Patents

Карбапенемовый антибиотик, композиция и способ получения

Info

Publication number
EA199800180A1
EA199800180A1 EA199800180A EA199800180A EA199800180A1 EA 199800180 A1 EA199800180 A1 EA 199800180A1 EA 199800180 A EA199800180 A EA 199800180A EA 199800180 A EA199800180 A EA 199800180A EA 199800180 A1 EA199800180 A1 EA 199800180A1
Authority
EA
Eurasian Patent Office
Prior art keywords
obtaining
composition
carbapenem antibiotic
prodrug
hydrate
Prior art date
Application number
EA199800180A
Other languages
English (en)
Other versions
EA000534B1 (ru
Inventor
Джеффри Э. Циммерман
Джон М. Уильямс
Пол Э. Бергквист
Лиза М. ДиМишель
Дэвид К. Дюбост
Майкл Дж. Кауфман
Дэниел Р. Сидлер
Уильям Э. Ханке
Original Assignee
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199800180(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612668.5A external-priority patent/GB9612668D0/en
Application filed by Мерк Энд Ко., Инк. filed Critical Мерк Энд Ко., Инк.
Publication of EA199800180A1 publication Critical patent/EA199800180A1/ru
Publication of EA000534B1 publication Critical patent/EA000534B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Описана фармацевтическая композиция, которая содержит соединение формулы (I) или его фармацевтически приемлемую соль, пролекарство или гидрат в стабилизированной форме и/или в комбинации с источником диоксида углерода.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800180A 1996-05-28 1997-05-23 Карбапенемовый антибиотик, композиция и способ получения EA000534B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation
PCT/US1997/008831 WO1997045430A1 (en) 1996-05-28 1997-05-23 Carbapenem antibiotic, composition and method of preparation

Publications (2)

Publication Number Publication Date
EA199800180A1 true EA199800180A1 (ru) 1998-08-27
EA000534B1 EA000534B1 (ru) 1999-10-28

Family

ID=26309530

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800180A EA000534B1 (ru) 1996-05-28 1997-05-23 Карбапенемовый антибиотик, композиция и способ получения

Country Status (34)

Country Link
EP (1) EP0863901B1 (ru)
JP (2) JPH11509871A (ru)
KR (2) KR100403497B1 (ru)
CN (1) CN1067074C (ru)
AT (1) ATE252584T1 (ru)
AU (1) AU710102B2 (ru)
BG (1) BG63821B1 (ru)
CA (1) CA2227994C (ru)
CO (1) CO4940412A1 (ru)
CY (1) CY2437B1 (ru)
CZ (1) CZ296381B6 (ru)
DE (1) DE69725696T2 (ru)
DK (1) DK0863901T3 (ru)
DZ (1) DZ2242A1 (ru)
EA (1) EA000534B1 (ru)
EE (1) EE04678B1 (ru)
ES (1) ES2208907T3 (ru)
HK (1) HK1016176A1 (ru)
HR (1) HRP970281B1 (ru)
HU (1) HU229426B1 (ru)
ID (1) ID16974A (ru)
IL (1) IL123078A (ru)
IS (1) IS2353B (ru)
MX (1) MX9800808A (ru)
NO (1) NO323815B1 (ru)
NZ (1) NZ329649A (ru)
PL (1) PL188917B1 (ru)
PT (1) PT863901E (ru)
RS (1) RS49583B (ru)
SI (1) SI0863901T1 (ru)
SK (1) SK284359B6 (ru)
TR (1) TR199800146T1 (ru)
TW (1) TW434014B (ru)
WO (1) WO1997045430A1 (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU725298B2 (en) * 1996-10-28 2000-10-12 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
WO1998057973A1 (en) * 1997-06-16 1998-12-23 Merck & Co., Inc. Stabilized carbapenem intermediates and synthetic use
US6180783B1 (en) * 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
ES2234689T3 (es) * 1999-10-29 2005-07-01 MERCK & CO., INC. Procedimiento de preparacion de composiciones de antibioticos a base de carbapenemo.
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CN101357918B (zh) * 2007-06-22 2011-05-18 山东轩竹医药科技有限公司 含有异硫脲基巯基吡咯烷的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
JPWO2009075309A1 (ja) * 2007-12-12 2011-04-28 大日本住友製薬株式会社 製剤組成物
CN101550138B (zh) * 2008-04-03 2011-05-18 山东轩竹医药科技有限公司 巯基氮杂环烷酰胺醇取代的培南衍生物
EP2505191A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Lyophilized Carbapenem antibiotic composition
WO2010113492A1 (ja) 2009-03-31 2010-10-07 三菱マテリアル株式会社 含フッ素ｎ－アルキルスルホニルイミド化合物及びその製造方法、並びにイオン性化合物の製造方法
GB2483591A (en) 2009-06-25 2012-03-14 Shell Int Research Water injection systems and methods
US8889384B2 (en) 2010-10-07 2014-11-18 Shell Oil Company Process for the production of alcohols from biomass
AU2011323322B2 (en) 2010-11-05 2015-03-12 Shell Internationale Research Maatschappij B.V. Treating biomass to produce materials useful for biofuels
US8609379B2 (en) 2010-12-20 2013-12-17 Shell Oil Company Process for the production of alcohols from biomass
PL2791344T3 (pl) 2011-12-15 2016-08-31 Shell Int Research Sposób obróbki produktów ubocznych z wytwarzania etanolu
WO2013173567A1 (en) 2012-05-17 2013-11-21 Shell Oil Company Methods and systems for processing biomass material
CN103860485A (zh) * 2012-12-18 2014-06-18 深圳市海滨制药有限公司 一种厄他培南钠冻干制剂及其制备方法
US20150299739A1 (en) 2014-04-17 2015-10-22 Shell Oil Company Processes for producing fermentation products
CA2954306C (en) 2014-08-14 2022-08-30 Shell Internationale Research Maatschappij B.V. Process for preparing furfural from biomass

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
PT863901E (pt) 2004-02-27
HUP9901567A2 (hu) 1999-09-28
YU4198A (sh) 1998-12-23
CZ25398A3 (cs) 1998-07-15
JP5255983B2 (ja) 2013-08-07
HU229426B1 (en) 2013-12-30
IL123078A0 (en) 1998-09-24
KR100403497B1 (ko) 2003-10-30
TW434014B (en) 2001-05-16
CY2437B1 (en) 2004-11-12
CN1198162A (zh) 1998-11-04
IS4663A (is) 1998-01-27
HK1016176A1 (en) 1999-10-29
NO980380L (no) 1998-03-16
MX9800808A (es) 1998-04-30
WO1997045430A1 (en) 1997-12-04
IS2353B (is) 2008-04-15
NO323815B1 (no) 2007-07-09
AU710102B2 (en) 1999-09-16
KR100344479B1 (ko) 2002-10-31
DE69725696T2 (de) 2004-07-29
ATE252584T1 (de) 2003-11-15
BG102273A (bg) 1998-09-30
JP2009084284A (ja) 2009-04-23
CN1067074C (zh) 2001-06-13
DZ2242A1 (fr) 2002-12-18
NO980380D0 (no) 1998-01-28
ES2208907T3 (es) 2004-06-16
CZ296381B6 (cs) 2006-03-15
SK284359B6 (sk) 2005-02-04
AU3077597A (en) 1998-01-05
NZ329649A (en) 1998-11-25
ID16974A (id) 1997-11-27
EP0863901B1 (en) 2003-10-22
IL123078A (en) 2002-03-10
EE04678B1 (et) 2006-08-15
SK10998A3 (en) 1998-08-05
SI0863901T1 (en) 2004-04-30
HRP970281B1 (en) 2002-04-30
CA2227994C (en) 2002-06-25
EA000534B1 (ru) 1999-10-28
PL188917B1 (pl) 2005-05-31
RS49583B (sr) 2007-04-10
DE69725696D1 (de) 2003-11-27
EE9800022A (et) 1998-08-17
HUP9901567A3 (en) 2000-03-28
CA2227994A1 (en) 1997-12-04
BG63821B1 (bg) 2003-02-28
HRP970281A2 (en) 1998-06-30
DK0863901T3 (da) 2004-02-16
PL324746A1 (en) 1998-06-08
TR199800146T1 (xx) 1998-06-22
KR19990036052A (ru) 1999-05-25
JPH11509871A (ja) 1999-08-31
CO4940412A1 (es) 2000-07-24
EP0863901A1 (en) 1998-09-16

Similar Documents

Publication Publication Date Title
EA199800180A1 (ru) Карбапенемовый антибиотик, композиция и способ получения
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
EA200200619A1 (ru) Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
EA200100688A1 (ru) АЗОТСОДЕРЖАЩИЕ ГЕТЕРОБИЦИКЛЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa
EA199900166A1 (ru) Замещенные 6,6-гетеробициклические производные
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
EA200000891A1 (ru) Кристаллическая форма 4-[5-метил-3-фенилизоксазол-4-ил] бензолсульфонамида
YU41199A (sh) Hinoksalindioni
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика
EA200101106A1 (ru) Фармацевтический комплекс
ATE282608T1 (de) Chinoxalindionen
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
AU562643B2 (en) N-arylpiperazine derivatives
EA199900688A1 (ru) Хиноксалиндионы
MY116202A (en) Carbapenem antibiotic, composition and method of preparation
ECSP972136A (es) Composicion y metodo de preparacion de un antibiotico de carbapemen
EA200100528A1 (ru) 1,4-диарил-2-фтор-1-бутен-3-ольные производные и их применение для получения 1,4-диарил-2-фтор-1,3-бутадиеновых и 1,4-диарил-2-фтор-2-бутеновых производных

Legal Events

Date Code Title Description
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
ND4A Extension of term of a eurasian patent

Designated state(s): AZ BY KZ KG TJ TM RU

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MK4A Patent expired

Designated state(s): AM AZ KZ KG MD TJ TM RU